Pricing Log in Create free account

Q32 Bio Inc. (QTTB) vs Sol-Gel Technologies Ltd. (SLGL)

Q32 Bio Inc. and Sol-Gel Technologies Ltd. are both Biotechnology companies. Q32 Bio Inc. and Sol-Gel Technologies Ltd. are of similar size ($231.3M and $224.9M). Sol-Gel Technologies Ltd. has negative trailing earnings, so its P/E is not meaningful; Q32 Bio Inc. trades at 2.5×. Sol-Gel Technologies Ltd. grew revenue faster over the last twelve months: −92.5% against −307.3%. Q32 Bio Inc. has the higher net margin (0.00% vs −910.1%) and the higher return on invested capital (0.00% vs −6,630.2%). Across the 15 metrics below, Q32 Bio Inc. leads on 14 and Sol-Gel Technologies Ltd. on 1.

Valuation

Metric QTTB SLGL Biotechnology median
P/E 2.49 n/m 8.50
P/S n/m 117.08 9.71
P/B 1.44 4.37 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales (8.25) 126.78 9.21
Earnings yield 40.16% (8.78%) (33.15%)
Free cash flow yield (8.43%) (10.12%) (25.50%)

Profitability

Metric QTTB SLGL Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin 0.00% (986.96%) 0.00%
Net margin 0.00% (910.14%) 0.00%
Free cash flow margin 0.00% (1,185.18%) 0.00%
Return on equity 72.14% (40.85%) (56.36%)
Return on assets 37.13% (35.11%) (48.04%)
Return on invested capital 0.00% (6,630.24%) 0.00%

Growth

Metric QTTB SLGL Biotechnology median
Revenue growth (TTM) (307.33%) (92.50%) 6.02%
EPS growth (last fiscal year) 148.96% 42.37% 30.26%
Revenue growth, 5-year CAGR 100.32% 17.19% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric QTTB SLGL Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 20.30 10.37 4.72
Net debt to EBITDA (2.21) 3.23 0.96

Dividend

Metric QTTB SLGL Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric QTTB SLGL Biotechnology median
Market cap 231.31m 224.92m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack